Quantbot Technologies’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-223,832
Closed -$3.58M 1776
2025
Q2
$3.58M Buy
223,832
+81,749
+58% +$1.46M 0.09% 315
2025
Q1
$2.76M Buy
142,083
+57,633
+68% +$1.21M 0.09% 337
2024
Q4
$1.86M Sell
84,450
-29,868
-26% -$575K 0.07% 429
2024
Q3
$1.93M Buy
114,318
+49,742
+77% +$738K 0.08% 402
2024
Q2
$772K Sell
64,576
-59,623
-48% -$666K 0.04% 619
2024
Q1
$1.38M Buy
124,199
+61,365
+98% +$626K 0.08% 392
2023
Q4
$544K Buy
62,834
+33,570
+115% +$261K 0.03% 703
2023
Q3
$224K Buy
+29,264
New +$220K 0.02% 873

Other funds holding CLBT

Quantbot Technologies's CLBT Position: Q3 2025 in Review

Quantbot Technologies sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 223,832 shares — an estimated $3.58M sold.

Quantbot Technologies first reported a position in CLBT in Q3 2023 and held it in 8 quarters. The position peaked at $3.58M in Q2 2025. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Quantbot Technologies reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Quantbot Technologies sold 223,832 Cellebrite shares in Q3 2025, an estimated $3.58M.
  • Quantbot Technologies first reported a position in Cellebrite in Q3 2023 and held it in 8 quarters.
  • Quantbot Technologies's Cellebrite position peaked at $3.58M in Q2 2025.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Quantbot Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.